FDA Inspection 1107092 — Community Blood Center of Greater Kansas City, An Operating Division of New York Blood Center, Inc.

Community Blood Center of Greater Kansas City, An Operating Division of New York Blood Center, Inc. — FEI 3014378690

The FDA completed an inspection of Community Blood Center of Greater Kansas City, An Operating Division of New York Blood Center, Inc. on October 16, 2019 in Olathe, KS. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
October 16, 2019
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Olathe, KS (United States)